首页> 外文期刊>Contraception >Operational assessments of Sayana? Press provision in Senegal and Uganda
【24h】

Operational assessments of Sayana? Press provision in Senegal and Uganda

机译:Sayana的运营评估?塞内加尔和乌干达的新闻规定

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Objective Sayana? Press (SP) is a unique injectable contraceptive (depot medroxyprogesterone acetate, or DMPA) administered subcutaneously in the UnijectTM injection system.1 SP simplifies the injection process; it requires no assembly of components and is easily disposable. This new technology appears to be well suited for community-based delivery of injectable contraception. The study objective was to evaluate SP management and administration in low-resource settings, focusing on how the delivery logistics, administration time, storage and waste-management requirements compare to the traditional intramuscular DMPA injectable (DMPA IM). Study design We conducted 58 semistructured interviews with clinic providers and community health workers in Senegal and Uganda to identify the merits, challenges and appeal of SP relative to DMPA IM. Results Providers identified logistical challenges with the management and administration of DMPA IM, including stock outs, transportation, storage constraints, and, in a few instances, waste disposal. Most providers (between 63% and 88%, depending on the logistics issue) do not expect SP to either aggravate or solve those problems. Some envisioned that SP could facilitate supply management (5%), storage (11%) and waste disposal (22%). The all-in-one packaging of SP was perceived to reduce the incidence of mismatched supplies (syringes and vials), and its smaller size was expected to ease space constraints and reduce the frequency of safety box incineration. Conclusion Adding SP to the method mix is unlikely to have a profound impact on clinic operations but may lessen logistical problems related to supply, storage and waste management. Implications Community health workers and clinic providers who administer SP may see some modest improvements in service delivery logistics. Particularly in settings where service delivery logistical challenges are more pronounced, offering SP may facilitate injectable contraceptive delivery.
机译:客观Sayana? Press(SP)是在UnijectTM注射系统中皮下给药的独特的可注射避孕药(醋酸甲羟孕酮,或DMPA)。1SP简化了注射过程;它不需要任何组件的组装,并且易于丢弃。这项新技术似乎非常适合以社区为基础的注射避孕药交付。研究目的是评估资源匮乏地区的SP管理和管理,重点是与传统的肌肉内DMPA注射剂(DMPA IM)相比,运送后勤,管理时间,存储和废物管理要求。研究设计我们对塞内加尔和乌干达的诊所提供者和社区卫生工作者进行了58次半结构化访谈,以确定SP相对于DMPA IM的优点,挑战和吸引力。结果提供者发现了DMPA IM的管理和管理面临的后勤挑战,包括缺货,运输,存储限制以及在少数情况下的废物处理。大多数提供商(介于63%到88%之间,具体取决于物流问题)都不希望SP加剧或解决这些问题。一些人设想SP可以促进供应管理(5%),存储(11%)和废物处置(22%)。 SP的多合一包装被认为可以减少不匹配的供应品(注射器和小瓶)的发生,并且其较小的尺寸有望减轻空间限制并减少安全箱焚化的频率。结论将SP添加到方法组合中对临床操作的影响不大,但可以减少与供应,存储和废物管理有关的后勤问题。含义管理SP的社区卫生工作者和诊所提供者可能会在服务交付物流方面看到一些适度的改进。特别是在服务交付后勤挑战更为突出的环境中,提供SP可能有助于注射避孕药具的交付。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号